Skip to main content
# Title Research Year
201 Evaluation of serum level of some angiogenic factors in
non hodgkin's lymphoma
2012
202 Phase II study of high dose thoracic radiation therapy with concurrent cisplatin and etoposide in unresectable non small cell lung cancer. 2012
203 Hypofractionation versus conventional fractionation radiotherapy in the adjuvant treatment of early breast cancer : local tumor control and tissue response 2011
204 GEMCITABINE AND CISPLATIN VERSUS METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED AND OR METASTATIC BILHARZIAL UROTHELIAL CARCINOMA OF THE BLADDER IN EGYPT. 2011
205 Des-gamma Carboxy Prothrombin, Alpha-Feto Protein and Alpha-Feto Protein L3 in Patients with Cirrhosis and Hepatocellular Carcinoma. 2011
206 GEMCITABINE AND CISPLATIN VERSUS METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED AND OR METASTATIC BILHARZIAL UROTHELIAL CARCINOMA OF THE BLADDER IN EGYPT. 2011
207 PHASE II STUDY OF THORACIC RADIATION THERAPY WITH CONCURRENT CISPLATIN AND ETOPOSIDE IN UNRESECTABLE NON-SMALL CELL LUNG CANCER 2011
208 PHASE II STUDY OF THORACIC RADIATION THERAPY WITH CONCURRENT CISPLATIN AND ETOPOSIDE IN UNRESECTABLE NON-SMALL CELL LUNG CANCER 2011
209 PHASE II STUDY OF THORACIC RADIATION THERAPY WITH CONCURRENT CISPLATIN AND ETOPOSIDE IN UNRESECTABLE NON-SMALL CELL LUNG CANCER 2011
210 PHASE II STUDY OF THORACIC RADIATION THERAPY WITH CONCURRENT CISPLATIN AND ETOPOSIDE IN UNRESECTABLE NON-SMALL CELL LUNG CANCER 2011